Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.099 | 0.003 |
mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.004 |
mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |